WORLDCARE CLINICAL COMMENCES DXA AND MRI SERVICES ON NON-ALCOHOLIC FATTY LIVER DISEASE STUDY

Boston, MA, June 15, 2020 -- WorldCare Clinical (WCC) a leading provider of imaging and endpoint assessment committeesfor hepatic clinical trials, today announced that it had commenced MRI and DXA(dual-energy…

Continue Reading WORLDCARE CLINICAL COMMENCES DXA AND MRI SERVICES ON NON-ALCOHOLIC FATTY LIVER DISEASE STUDY

NAVIDEA BIOPHARMACEUTICALS SIGNS LETTER OF INTENT WITH WORLDCARE CLINICAL TO PARTNER ON NAVIDEA’S RHEUMATOID ARTHRITIS CLINICAL IMAGING WORKFLOW AND COMMERCIALIZATION

DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals,Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it has signed…

Continue Reading NAVIDEA BIOPHARMACEUTICALS SIGNS LETTER OF INTENT WITH WORLDCARE CLINICAL TO PARTNER ON NAVIDEA’S RHEUMATOID ARTHRITIS CLINICAL IMAGING WORKFLOW AND COMMERCIALIZATION

WORLDCARE CLINICAL EXPANDS ITS ONCOLOGY CLINICAL TRIAL SERVICES TO INCLUDE ASSESSMENTS OF DRUG-INDUCED CANCERS

Boston, MA, March 12, 2019 -- WorldCare Clinical (WCC), aleading CRO focused on maximizing the precision and accuracy of independent endpoint assessments in clinical trials, today announced its integrated pathology…

Continue Reading WORLDCARE CLINICAL EXPANDS ITS ONCOLOGY CLINICAL TRIAL SERVICES TO INCLUDE ASSESSMENTS OF DRUG-INDUCED CANCERS
OUTSOURCING IN CLINICAL TRIALS – EAST COAST
Digital global business network connection and people walking in the city with technology design

OUTSOURCING IN CLINICAL TRIALS – EAST COAST

King of Prussia, PA, May 21, 2018  -- WorldCare Clinical, a leading provider of imaging services for clinical trials, will be at the show and featuring its imaging core lab…

Continue Reading OUTSOURCING IN CLINICAL TRIALS – EAST COAST